Michael Joffre, Ph.D. The 2023 <em>IAM Patent 1000</em> deemed Michael "a seasoned trial lawyer who has advocated in courts throughout the United States, boasting an impressive track record."

Michael Joffre, Ph.D.

Director

mjoffre@sternekessler.com
+1 202.772.8856
LinkedIn

Overview

Michael Joffre is a director in Sterne Kessler’s Trial & Appellate Practice Group. Mike is co-chair of the firm’s appellate practice and focuses on intellectual property disputes before trial and appellate courts. He has argued and won cases throughout the country, including in Texas, California, Wisconsin, Delaware, New Jersey, the U.S. International Trade Commission (ITC), the U.S. Patent Trial and Appeal Board (PTAB), and the Federal Circuit. He has also represented clients before the U.S. Supreme Court at both the certiorari and merits stages.

Mike is a skilled litigator, adept at handling cases involving a variety of technologies and products, including microprocessors, telecommunications networks, mechanical devices, consumer products, and computer software. He also draws on his strong scientific background to counsel pharmaceutical companies on matters related to Abbreviated New Drug Applications (ANDAs).

Prior to entering law school, Mike worked as a research scientist in cosmology at the University of Chicago and Fermilab. Following law school, he served as a law clerk for Judge William C. Bryson, U.S. Court of Appeals for the Federal Circuit, 2004-2005. He received his J.D. from Harvard Law School, a Ph.D. from the University of Chicago, and a B.S. from the Massachusetts Institute of Technology.

Representative Matters

  • Limelight Networks Inc. v. Akamai Techs., Inc., No. 12-786 (U.S. Sup. Ct. 2014) (Represented Limelight; obtained reversal of Federal Circuit decision, which had dramatically broadened the law of indirect infringement.)
  • St. Clair Intellectual Property Consultants, Inc. v. Toshiba America Inc., No. 16-1355 (Fed. Cir. 2016) (Represented St. Clair; obtained summary affirmance on appeal that case was not exceptional)
  • Certain Audio Processing Hardware and Software and Products Containing Same, Inv. No. 337-TA-949 (U.S.I.T.C. 2016) (Represented Dell; defended Dell against claims of infringement and was the first party ever to successfully seek use of the ITC’s 90-day pilot program; then, obtained favorable settlement on eve of hearing.)
  • Stragent, LLC v. Intel Corp., No. 6:11-cv-421-TBD-JDL (E.D. Tex. 2014) (Represented Stragent; acted as appellate counsel during district court trial to ensure all matters of law were correctly preserved; successfully defended against claims that the case was exceptional.)
  • Ricoh Co., Ltd. v. Quanta Computer, Inc., No. 06-cv-462-bbc (W.D. Wis. 2010) (Representing Ricoh; obtained reversal on appeal of unfavorable summary judgment ruling in patent infringement case brought by Ricoh against Taiwanese maker of optical disc drives; then, on remand, obtained $14.5 million jury verdict for patentee.)

Accolades

  • Patexia, “Best-Performing Patent Litigators Representing Plaintiffs (Top 100)” (2023)
  • Managing IP, “IP Star” (2023 – 2020)
  • IAM Patent 1000, “Washington, DC: Patent Litigation (Bronze Band)” (2023 – 2018)
  • Super Lawyers, “Super Lawyers – Washington DC” (2024 – 2022)
  • Patexia, “100 Most Active CAFC Attorneys Representing Patent Appellants (Top 50)” (2021)
  • Patexia, “100 Most Active CAFC Attorneys Overall (Representing Appellants and Appellees) (Top 50)” (2021)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellees (Top 50)” (2021)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellants (Top 10)” (2021)
  • Patexia, “100 Best Performing CAFC Attorneys Overall (Representing Appellants or Appellees) (Top 10)” (2021)

Education

  • B.S., Harvard Law School, magna cum laude
  • B.S., Astrophysics, Harvard Law School
  • B.S., Physics, Harvard Law School

Admissions

  • District of Columbia
  • Massachusetts
  • Supreme Court of the United States
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the First Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • U.S. District Court for the District of Columbia
  • U.S. District Court for the District of Massachusetts

Clerkships

  • U.S. Court of Appeals for the Federal Circuit

Related News & Insights From Michael Joffre, Ph.D.

Press Release Eighteen Sterne Kessler Attorneys Recognized as 2024 “Super Lawyers” and “Rising Stars” Sterne, Kessler, Goldstein & Fox April 25, 2024
Firm Announcements Sterne Kessler Secures PTAB Win on Behalf of Client RoboticVISIONTech Sterne, Kessler, Goldstein & Fox April 2, 2024
Press Release Sterne Kessler Publishes Federal Circuit IP Appeals: Summaries of Key 2023 Decisions Report Sterne, Kessler, Goldstein & Fox January 24, 2024
Firm Announcements Federal Circuit Affirms Sweet Win for SweeGen in Patent Invalidity Battle Sterne, Kessler, Goldstein & Fox January 3, 2024
Press Release Sterne Kessler Publishes Report Examining Key 2022 Federal Circuit Rulings on PTAB and ITC Appeals Sterne, Kessler, Goldstein & Fox February 7, 2023
In the News Patexia Insight 161: Top CAFC Law Firms of 2022 Patexia December 1, 2022
In the News Korean Co. Can't Be First To Invent CRISPR, PTAB Told Law360 September 12, 2022
In the News Stevia Patent Claims Fall After SweeGen Challenge Law360 May 24, 2022
Press Release Super Lawyers Recognizes 14 Attorneys as 2022 “Super Lawyers” and “Rising Stars” Sterne, Kessler, Goldstein & Fox May 1, 2022
In the News ImmunoGen Patent Application Suit Sent Back to Court (1) Bloomberg Law March 25, 2022
In the News Litigator of the Week Runners-Up and Shout Outs Law.com February 18, 2022
In the News Federal Circuit Tosses Naloxone Patents Law Street Media February 11, 2022
In the News Teva Win Invalidating Narcan Patents Upheld by Federal Circuit Bloomberg Law February 10, 2022
In the News Split Fed. Circ. Won't Restore 4 Narcan Patents Law360 February 10, 2022
In the News AbbVie Settles Patent Dispute Over Muscle Stimulation Tech Law360 September 7, 2021
In the News Federal Circuit Backs Caterpillar Rival's Patent Win Law360 March 15, 2021
In the News Justices Skip Case Horizon Said Puts 32K Patents At Risk Law360 November 3, 2020
Press Release Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology Sterne, Kessler, Goldstein & Fox P.L.L.C. October 8, 2020
In the News Top 6 Patent Rulings Of 2020: A Midyear Report Law360 June 29, 2020
Press Release Sterne, Kessler, Goldstein & Fox and 15 Directors Earn Top Rankings in IAM Patent 1000 Sterne, Kessler, Goldstein & Fox P.L.L.C. June 16, 2020
In the News Teva Invalidates Opiant Patents In Narcan Suit Law360 June 5, 2020
Press Release Sterne Kessler Ranked and 13 Directors Named “IP Stars” by Managing Intellectual Property Sterne, Kessler, Goldstein & Fox P.L.L.C. May 5, 2020
Press Release Sterne Kessler Publishes Two Reports -- PTAB Year in Review and Federal Circuit Appeals from the PTAB Sterne, Kessler, Goldstein & Fox P.L.L.C. March 17, 2020
In the News Rival Says Allergan Muscle Toner Not As Strong As Claimed Law360 February 20, 2020
Press Release Sterne, Kessler, Goldstein & Fox Summarizes Key Decisions in 2019 Federal Circuit Appeals From The PTAB Report Sterne, Kessler, Goldstein & Fox P.L.L.C. February 3, 2020
In the News PTAB Cuts Down Two More Allergan Restasis Patents Law360 September 30, 2019
Press Release Sterne Kessler Prominent Again in Intellectual Asset Management Magazine’s "IAM Patent 1000" Sterne, Kessler, Goldstein & Fox P.L.L.C June 12, 2019
In the News Supreme Court Refuses 'Blocking Patent' Rule Case Law360 June 3, 2019
In the News Fed. Circ. Won't Revisit Restasis Patent Ruling Law360 April 6, 2019
In the News Fed. Circ. Won't Revisit Restasis Patent Ruling Law360 March 6, 2019
In the News Restasis Patent Redo Bid 'Inappropriate,' Fed. Circ. Told Law360 February 15, 2019
In the News Fed. Circ. Affirms Toshiba Win Over LCD Screen IP Suit Law360 January 22, 2019
In the News The Biggest Patent Cases of 2018 Law360 December 17, 2018
In the News Fed. Circ. Erases Seoul Semiconductor's $4M Patent Award Law360 November 19, 2018
In the News Fed. Circ. Won't Restore Allergan's Restasis Patent Claims Law360 November 13, 2018
In the News Fed. Circ. Urged Not to Stay Immunity Ruling for Appeal Law360 November 6, 2018
In the News Allergan, Generic Cos. Battle Over Restasis Launch Plans Law360 October 31, 2018
In the News Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing Law360 October 22, 2018
In the News No Need To Reconsider Immunity At PTAB, Fed. Circ. Hears Law360 September 19, 2018
In the News Generics Cos. Urge Fed. Circ. To Upend Depomed Patent Win Law360 September 4, 2018
In the News Fed. Circ. Says Tribal Immunity Doesn't Apply In IPR Law360 July 20, 2018
In the News Prison Phone Rivals Reach Confidential Deal in IP Row Law360 December 5, 2017
In the News Sterne Kessler Adds 2 Kellogg Huber IP Pros as Directors Law360 January 30, 2017
In the News Washington-Area Appointments and Promotions for Jan. 30 The Washington Post January 29, 2017
In the News Sterne, Kessler, Goldstein & Fox Adds Directors World Intellectual Property Review January 26, 2017
Press Release Litigators J.C. Rozendaal and Mike Joffre Join Sterne Kessler fivejars January 25, 2017